Blood GFAP as an emerging biomarker in brain and spinal cord disorders
Ahmed Abdelhak(University of California, San Francisco), Hayrettin Tumani(University Hospital Ulm), Albert C. Ludolph(German Center for Neurodegenerative Diseases), Ari Green(University of California, San Francisco), Jens Kühle(University of Basel), Patrick Oeckl(Universität Ulm), Axel Petzold(University College London), Matteo Foschi(University of L'Aquila), Markus Otto(University Hospital in Halle), André Huss(Universität Ulm), John K. Yue(San Francisco General Hospital), Samir Abu‐Rumeileh(Martin Luther University Halle-Wittenberg), Geoffrey T. Manley(University of California, San Francisco), Lucio D’Anna(Charing Cross Hospital)
Cited by 809
Related Papers
Longitudinal analysis reveals high prevalence of Epstein-Barr virus associated with multiple sclerosis
|Science|2022|2k
Traumatic brain injury: progress and challenges in prevention, clinical care, and research
|The Lancet Neurology|2022|1.3k
Serum neurofilament dynamics predicts neurodegeneration and clinical progression in presymptomatic Alzheimer’s disease
|Nature Medicine|2019|948
Haploinsufficiency of TBK1 causes familial ALS and fronto-temporal dementia
|Nature Neuroscience|2015|782